Season 2026-2027
This protocol describes three study modules that all investigate the same study population and collect information via a common data collection:
- Surveillance study of respiratory pathogens in adults hospitalised for serious acute respiratory infection
- Brand-specific COVID-19 vaccine effectiveness against severe COVID-19 disease
- Brand-specific respiratory syncytial virus vaccine effectiveness
Previous seasons
- Surveillance study:
Surveillance Study protocol V2.0 21 Apr 2025
Surveillance Study protocol V1.0 21 Mar 2024 - COVID-19 vaccine effectiveness study:
COVID-19 Vaccine Effectiveness protocol V7.0_21 Feb 2025
COVID-19 Vaccine Effectiveness protocol V6.0_21 Mar 2024
COVID-19 Vaccine Effectiveness protocol V5.0_18 Sep 2023
COVID-19 Vaccine Effectiveness protocol V4.0_10 Oct 2022
COVID-19 Vaccine Effectiveness protocol V3.3_23 Dec 2021
COVID-19 Vaccine Effectiveness protocol V3.1_02 Jun 2021 - Respiratory Syncytial Virus (RSV) vaccine effectiveness study:
RSV Vaccine Effectiveness protocol V3.0 21 Feb 2025
RSV Vaccine Effectiveness protocol V2.0_07 Jun 2024
Multi-specimen study
id.DRIVE multi-specimen pilot study protocol V2.0 4 Feb 2026
id.DRIVE multi-specimen pilot study protocol V1.0_18 November 2025
id.DRIVE overview:
Poster (coming soon)
